ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag congress genetics genomics

USDA Proposes Ambitious New Plant Genome Initiative
Christopher Anderson | Aug 6, 1989 | 4 min read
WASHINGTON-In an ambitious answer to the National Institutes of Health's Human Genome Project, the U.S. Department of Agriculture has sprouted plans for a parallel project to map the genetic structure of key food plants. The proposal, presented by USDA program manager Jerome Miksche at a meeting of the NIH genome project's advisory committee in June, would identify genetic traits that can increase yield and disease resistance. The price tag is estimated to be $500 million over 10 years. In recen
Watson Departure Vexes Genome Experts
Scott Veggeberg | May 24, 1992 | 4 min read
They fear that funding support for their vast gene-mapping project could erode now that the Nobelist is leaving While the head of the nation's premier health agency may not be losing sleep over the resignation of James Watson as head of the Human Genome Project (HGP), many genetic researchers are distressed to see him go. Genome scientists interviewed for this article say it will be difficult for the National Institutes of Health, via its search committee, to find someone with the same drive
Planning the Future of Plant Genomics
Eugene Russo | Jul 21, 2002 | 5 min read
Image: Courtesy of National Sciences Foundation Arabidopsis Plant genomics researchers stand at a crossroads. Behind them are the completed genome sequences of rice1 and the model mustard plant Arabidopsis thaliana.2 Now, armed with insights gained from both plant and animal sequencing projects, plant biologists must decide how to proceed with future sequencing, proteomics, and functional genomics endeavors--and how to allot precious basic research dollars while, at the same time, keeping
obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
The Scientist Staff | Mar 28, 2024
D Dollars
Paul Smaglik | Jan 18, 1998 | 8 min read
SEARCHING FOR IDENTITY: USDA Undersecretary Mylie Gonzalez wants to give the agency a higher research profile. Image is everything for federal agencies that compete for a frozen pool of research dollars. Congress associates the National Institutes of Health with cancer cures, the National Science Foundation with sound basic research, and the United States Department of Agriculture (USDA) with subsidies, according to USDA officials. Although USDA will spend $1.6 billion on basic and applied re
Clinton, Blair Stoke Debate on Gene Data
Ricki Lewis | Apr 2, 2000 | 7 min read
President Bill Clinton and British Prime Minister Tony Blair's brief statement of March 14 supporting free access to human genome information unleashed a slew of clichés, including "too little too late" and "water under the bridge." But initial misinterpretation of the statement led to a temporary slide in biotech stocks. By the end of the day, Celera Genomics Corp. of Rockville, Md., had dropped 19 percent, while Incyte Pharmaceuticals of Palo Alto, Calif., plummeted 27 percent. Even thoug
Biotech Faces Evolving Patent System
Douglas Steinberg | Mar 5, 2000 | 8 min read
Like medieval alchemists, modern biologists apply intricate, esoteric protocols to lowly matter, such as bacteria and rodents. Unlike alchemists, biologists successfully transmute these creatures into gold--disease-fighting pharmaceuticals and profits accruing from them. An indispensable ingredient in this dross-to-drug process is patent protection, which preserves monopoly and attracts investment. Unfortunately, the patent system isn't as ideal a catalyst as the chimerical philosopher's stone s
Notebook
The Scientist Staff | Mar 2, 1997 | 8 min read
Monday mornings can be tough, even if you're Bill Gates. The head of Redmond, Wash.-based Microsoft Corp. ran into a few glitches at a presentation he was giving at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. In the middle of a demonstration on February 17 aimed at showing how Web browsers and E-mail will soon merge, the modem connection failed. A computer-vision demonstration by a Microsoft researcher didn't work, either. Then, during a ques
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Run a Search

ADVERTISEMENT